What is NDC 70573-099?

70573-099 is the product NDC for Ryplazim (plasminogen), Plasminogen 68.8 mg/1 injection, powder, lyophilized, for solution, listed with the FDA by Kedrion Biopharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Kedrion Biopharma, Inc., NDC labeler code 70573. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ryplazim?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ryplazim NDC 70573-099 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70573-099Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70573-0099Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70573-099-02	7057300990270573009902	1 VIAL, GLASS in 1 CARTON (70573-099-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (70573-099-01)Marketed from Jun 4, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ryplazim
Generic name (nonproprietary): plasminogen
Active ingredients: Plasminogen — 68.8 mg/1
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Kedrion Biopharma, Inc.NDC labeler code 70573
Product type: Plasma derivative
Marketing category: BLA — Biologics License ApplicationApplication BLA 125659
Marketing start: Jun 4, 2021
Listing expires: Dec 31, 2027
Identifiers: Product ID 70573-099_3083ad46-3f9f-4d4a-b567-f9de9b52bae9SPL ID 3083ad46-3f9f-4d4a-b567-f9de9b52bae9

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470573009902 followed by a unit qualifier and the quantity

Package 70573-0099-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 70573-099

What is NDC 70573-099?: 70573-099 is the product NDC for Ryplazim (plasminogen), Plasminogen 68.8 mg/1 injection, powder, lyophilized, for solution, listed with the FDA by Kedrion Biopharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ryplazim (Plasminogen).
What is the active ingredient?: Plasminogen.
Who is the labeler?: Kedrion Biopharma, Inc., NDC labeler code 70573. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ryplazim?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Ryplazim (Plasminogen) NDC 70573-099